

.png)

Understanding Complex Tumor Biology through AGENTIC AI
Deep, Cancer Specific NGS Panels;
End the Biomarker Black Box
Tumor-type–tuned panels interrogate more relevant genes/regions at higher depth—so you see drivers, fusions, CNVs, splice/promoter changes others miss.
Fewer “no-call OR not assessed” gaps; more actionable findings.
Built for first-line and beyond, with resistance pathways in scope.

For Oncologists
gSage Deep Research AI Agent: Evidence Based Oncology Intelligence at Your Fingertips
Generate a Personalized Patent Research Report in Minutes for Tumor Board Briefing and Documentation
- Therapy Guidance: FDA-approved therapies, dosage calculations, and treatment guidelines with concise summaries.
- Trusted Evidence: Transparent, traceable answers with high-quality, vetted references.
- Generate Tumour Board Brief, Cancer Board Dossier and Sync with EHR. Power.
- Gen AI Care worflows for Clinical Decision Support, Care Triage and Patient Monitoring.
- Trial Matching: Search, review, and match patients to clinical trials in minutes.
- Future-Ready: Explore CME credit opportunities tied to validated clinical searches.
Bringing Precision Oncology to the Point of Care
GeneSilico’s multi-modal AI platform delivers real-time, evidence-based insights at every stage of cancer care.
From diagnosis through treatment planning, our Deep Precision Oncology system provides oncologists with the clarity, confidence, and precision needed to personalize care and improve outcomes — directly at the point of care.

For Cancer Hospitals
Transform and Modernize your Cancer Care Operations with Clinical AI Assistant and Gen AI Workflows

For Health Systems
First-of-Its-Kind NGS Panels for Precision Cancer Care
GeneSilico’s cancer-specific next-generation sequencing (NGS) panels provide oncologists with unparalleled insights into tumor biology. Our breast cancer panel, for example, analyzes 68 critical genes to uncover actionable mutations and guide the most effective treatment choices.
Get Started
GeneSilico Ordering Portal: Seamless Access to Precision NGS Testing



The First AI Clinical Assistant for Precision Oncology at the Point of Care
GeneSilico’s gSage AI Assistant empowers oncologists to match the right treatment to the right patient at the right time. Continuously updated with the latest therapy insights, gSage builds personalized plans based on genetic mutations, biomarkers, and response probabilities. Seamlessly integrated into EHR workflows, it accelerates decision-making — turning cutting-edge science into real-time bedside action.
.jpg)